Relationship Between Serum Ustekinumab Trough Concentration and Clinical and Biochemical Disease Activity: A Real-World Study in Adult Patients with Crohn's Disease.

MLA

Nguyen, Khue M., et al. “Relationship Between Serum Ustekinumab Trough Concentration and Clinical and Biochemical Disease Activity: A Real-World Study in Adult Patients with Crohn’s Disease.” European Journal of Drug Metabolism and Pharmacokinetics, vol. 48, no. 3, May 2023, pp. 271–79. EBSCOhost, https://doi.org/10.1007/s13318-023-00824-w.

APA

Nguyen, K. M., Mattoo, V. Y., Vogrin, S., Basnayake, C., Connell, W. R., Ding, N. S., Flanagan, E., Kamm, M. A., Lust, M., Niewiadomski, O., Schulberg, J. D., & Wright, E. K. (2023). Relationship Between Serum Ustekinumab Trough Concentration and Clinical and Biochemical Disease Activity: A Real-World Study in Adult Patients with Crohn’s Disease. European Journal of Drug Metabolism and Pharmacokinetics, 48(3), 271–279. https://doi.org/10.1007/s13318-023-00824-w

Chicago

Nguyen, Khue M, Vandita Y Mattoo, Sara Vogrin, Chamara Basnayake, William R Connell, Nik S Ding, Emma Flanagan, et al. 2023. “Relationship Between Serum Ustekinumab Trough Concentration and Clinical and Biochemical Disease Activity: A Real-World Study in Adult Patients with Crohn’s Disease.” European Journal of Drug Metabolism and Pharmacokinetics 48 (3): 271–79. doi:10.1007/s13318-023-00824-w.